Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Emma Nealon is an analyst at Cantor Fitzgerald. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 04/01/2025
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 08/14/2023 | EQ | Buy Now | Equillium | $0.55 | 409.09% | Emma Nealon8% | → $2.8 | Reiterates | Overweight → Overweight | Get Alert |
| 09/15/2021 | EQ | Buy Now | Equillium | $0.55 | 2445.46% | Emma Nealon8% | → $14 | Initiates | → Overweight | Get Alert |
| 06/29/2021 | MGTA | Buy Now | Magenta Therapeutics | — | — | Emma Nealon8% | → $320 | Initiates | → Overweight | Get Alert |
| 05/28/2021 | HARP | Buy Now | Harpoon Therapeutics | — | — | Emma Nealon8% | → $400 | Initiates | → Overweight | Get Alert |
| 04/21/2021 | ETNB | Buy Now | 89bio | $7.12 | 714.61% | Emma Nealon8% | → $58 | Initiates | → Overweight | Get Alert |
| 11/13/2019 | HARP | Buy Now | Harpoon Therapeutics | — | — | Emma Nealon8% | $230 → $240 | Maintains | Outperform | Get Alert |
